Results 131 to 140 of about 46,872 (214)

Comparative Efficacy of SGLT2 Inhibitors in MASLD: Bayesian Network Meta-Analysis of CAP-LSM Outcomes and Time Effects. [PDF]

JGH Open
Gomez DP, Hababag WF, Ong-Ramos CC.
europepmc   +1 more source

SGLT2 inhibitors preserve serum chloride in non-diabetic CKD: a propensity-matched and LASSO regression analysis. [PDF]

Ren Fail
Matsui M, Kosugi T, Kitamura S, Nishimoto M, Itano A, Yamamoto M, Yabuta H, Oda A, Kawakami M, Tsushima H, Okamoto K, Eriguchi M, Samejima KI, Tsuruya K.   +13 more
europepmc   +1 more source

Impact of Reduced Renal Function on the Glucose-Lowering Effects of Luseogliflozin, a Selective SGLT2 Inhibitor, Assessed by Continuous Glucose Monitoring in Japanese Patients with Type 2 Diabetes Mellitus [PDF]

, 2016

core   +1 more source

Renoprotective effects of SGLT2 inhibitors in patients with Fabry disease. [PDF]

Mol Genet Metab Rep
Okamoto H, Goto S, Fujita M, Fujii H.
europepmc   +1 more source

Can SGLT2 Inhibitors Prevent Atrial Fibrillation in HFpEF? [PDF]

Balkan Med J
Özlek B.
europepmc   +1 more source

SGLT2 Inhibitors in Glomerulonephritis: Beyond Nephroprotection? [PDF]

J Clin Med
Del Vecchio L, Peiti S, Pucci Bella G, Locatelli F.   +3 more
europepmc   +1 more source

SGLT2 Inhibitors in Combination Therapies for Tumors: A Novel Approach to Synergistic Treatment Strategies. [PDF]

Drug Des Devel Ther
Su H, Li X, Wang S, Yang X, Jiang L, Luo H, Li Y, Zhou J, Huang Y, Li M.   +9 more
europepmc   +1 more source

Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Prevention: Evidence From Randomized Outcomes Trials. [PDF]

JACC Adv
Gerstein HC, Sattar N.
europepmc   +1 more source

Blood Pressure-Lowering Effect of SGLT2 Inhibitors in Patients Without Antihypertensive Treatment: A Real-World Data Analysis. [PDF]

J Clin Hypertens (Greenwich)
Ito R, Satoh M, Hashimoto H, Nobayashi H, Izumi S, Toyama M, Iwabe Y, Suzuki Y, Hirose T, Nakayama S, Murakami T, Sasaki M, Metoki H.   +12 more
europepmc   +1 more source

The impact of initiating SGLT2 inhibitors on eGFR: a pilot study at a secondary hospital in Malaysia. [PDF]

BMC Res Notes
Bay SS, Baharom NH, Zaihan AF.
europepmc   +1 more source